Understanding the Perspectives and Experiences of Canadian Psoriasis Patients with Diverse Skin Tones
-
By
-
H. Chih-ho Hong
-
Tessa Carr
-
Frankie Tai
-
Saad Mirza
-
Omair Lakhani
-
Laura Park-Wyllie
-
Marissa Joseph
-
April 9, 2026
-
Clinical Scorecard: Understanding the Perspectives and Experiences of Canadian Psoriasis Patients with Diverse Skin Tones
At a Glance
| Category | Detail |
|---|
| Condition | Psoriasis, a chronic immune-mediated inflammatory disease with cutaneous and systemic manifestations |
| Key Mechanisms | Immune-mediated inflammation affecting skin and systemic health; presentation and management influenced by skin tone |
| Target Population | Canadian patients with psoriasis across diverse ethnicities and skin tones |
| Care Setting | Primary care (GP referral) and dermatology specialist care within Canadian healthcare system |
Key Highlights
- Non-white patients with psoriasis report more frequent misdiagnosis and delays in care compared to white patients.
- Non-white patients experience greater emotional and social burden and face more barriers to accessing effective treatment.
- There is a strong expressed need among non-white patients for culturally competent care, mental health support, and advocacy.
Guideline-Based Recommendations
Diagnosis
- Recognize that psoriasis presentation may differ by skin tone, necessitating culturally competent diagnostic approaches.
- Address potential delays in diagnosis due to referral requirements and misdiagnosis, especially in non-white patients.
Management
- Improve access to effective psoriasis treatments for non-white patients by reducing systemic barriers.
- Incorporate mental health and advocacy support as part of comprehensive psoriasis care, particularly for non-white populations.
Monitoring & Follow-up
- Monitor emotional and social burden in psoriasis patients, with attention to disparities by ethnicity and skin tone.
- Evaluate treatment access and patient satisfaction regularly to identify and address care gaps.
Risks
- Be aware of increased risk of misdiagnosis and delayed treatment in non-white patients, which may worsen disease outcomes.
- Recognize the psychosocial risks including stigma and emotional distress disproportionately affecting patients with skin of colour.
Patient & Prescribing Data
Canadian adults with psoriasis, stratified by white and non-white ethnic groups
Non-white patients report greater barriers to accessing effective treatments, indicating a need for improved equitable prescribing practices.
Clinical Best Practices
- Implement culturally competent care models tailored to diverse skin tones to improve diagnosis and management of psoriasis.
- Facilitate timely referrals from primary care to dermatology to reduce diagnostic delays.
- Integrate mental health resources and patient advocacy into psoriasis care pathways.
- Use patient-reported experiences to guide improvements in treatment access and support services.
References
